2006 GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN SIGNIFICANTLY IMPROVES VIROLOGIC RESPONSE AND ALT NORMALIZATION AT END-OF-TREATMENT AND IMPROVES SVR24 COMPARED TO PEG-IFN/RIBAVIRIN IN GENOTYPE-1 CHRONIC HCV PATIENTS

✍ Scribed by Jacobson, I.M.; McHutchison, J.G.; Boyer, T.D.; Schiff, E.R.; Everson, G.T.; Pockros, P.J.; Chasen, R.M.; Vierling, J.M.; Lawitz, E.J.; Kugelmas, M.; Tsai, N.C.; Shiffman, M.L.; Buynak, R.J.; Sheikh, A.M.; Armstrong, B.; Rodell, T.C.; Apelian, D.

• Book ID: 121936035
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 71 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(10)61197-X